DXC Cuts Guidance Amid AI Hopes and Deal Talk

DXC Technology's fiscal Q2 2027 results have prompted a downward revision of its full-year revenue and adjusted earnings per share guidance. This recalibration follows softer bookings and a slower conversion of its sales pipeline. The company's stock had previously experienced significant gains, driven by speculation surrounding a potential US$2.4 billion sale of its insurance software and services division and its strategic push into artificial intelligence offerings.

Despite a recent surge in share price, the guidance cut has tempered optimism, drawing renewed attention to persistent revenue pressures. Investors are now weighing the execution risks associated with DXC's transition from labor-intensive services to AI-driven, product, and SaaS-led offerings. The successful implementation of a planned US$1.0 to $1.5 billion cost reduction and margin uplift is critical.

Currently, DXC Technology trades at 20.8 times earnings, below industry peers and the broader US IT sector. However, some analyses suggest the stock is overvalued at US$14.98, with a fair value estimate of US$12.50. Key challenges include ongoing organic revenue declines in segments like GIS and the overhang from a securities fraud investigation.